85 related articles for article (PubMed ID: 8825618)
1. Inhibition of human immunodeficiency virus infection of CD4+ cells by CD4-free glycopeptides from monocytic U937 cells.
Mbemba E; Carré V; Atemezem A; Saffar L; Gluckman JC; Gattegno L
AIDS Res Hum Retroviruses; 1996 Jan; 12(1):47-53. PubMed ID: 8825618
[TBL] [Abstract][Full Text] [Related]
2. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1).
Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC
AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938
[TBL] [Abstract][Full Text] [Related]
3. Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes.
Seddiki N; Rabehi L; Benjouad A; Saffar L; Ferriere F; Gluckman JC; Gattegno L
Glycobiology; 1997 Dec; 7(8):1229-36. PubMed ID: 9455924
[TBL] [Abstract][Full Text] [Related]
4. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
Fenouillet E; Clerget-Raslain B; Gluckman JC; Guétard D; Montagnier L; Bahraoui E
J Exp Med; 1989 Mar; 169(3):807-22. PubMed ID: 2538547
[TBL] [Abstract][Full Text] [Related]
5. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
Mbemba E; Benjouad A; Saffar L; Gattegno L
Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody directed to sulfatide inhibits the binding of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein to macrophages but not their infection by the virus.
Seddiki N; Ramdani A; Saffar L; Portoukalian J; Gluckman JC; Gattegno L
Biochim Biophys Acta; 1994 Feb; 1225(3):289-96. PubMed ID: 8312376
[TBL] [Abstract][Full Text] [Related]
7. alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans.
Rabehi L; Ferriere F; Saffar L; Gattegno L
Glycoconj J; 1995 Feb; 12(1):7-16. PubMed ID: 7795416
[TBL] [Abstract][Full Text] [Related]
8. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
Delézay O; Hammache D; Fantini J; Yahi N
Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus type 1.
Haidar M; Seddiki N; Gluckman JC; Gattegno L
Glycoconj J; 1992 Dec; 9(6):315-23. PubMed ID: 1284814
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
[TBL] [Abstract][Full Text] [Related]
11. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages.
Nguyen DG; Hildreth JE
Eur J Immunol; 2003 Feb; 33(2):483-93. PubMed ID: 12645947
[TBL] [Abstract][Full Text] [Related]
12. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
Witvrouw M; Fikkert V; Hantson A; Pannecouque C; O'keefe BR; McMahon J; Stamatatos L; de Clercq E; Bolmstedt A
J Virol; 2005 Jun; 79(12):7777-84. PubMed ID: 15919930
[TBL] [Abstract][Full Text] [Related]
13. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
Jiang A; Fisher H; Pomerantz RJ; Dornburg R
Hum Gene Ther; 1999 Nov; 10(16):2627-36. PubMed ID: 10566890
[TBL] [Abstract][Full Text] [Related]
14. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
Raja NU; Vincent MJ; Jabbar MA
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
[TBL] [Abstract][Full Text] [Related]
15. Interaction of an anti-HIV peptide, T22, with gp120 and CD4.
Tamamura H; Otaka A; Murakami T; Ishihara T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
Biochem Biophys Res Commun; 1996 Feb; 219(2):555-9. PubMed ID: 8605026
[TBL] [Abstract][Full Text] [Related]
16. Jacalin, a lectin with anti-HIV-1 properties, and HIV-1 gp120 envelope protein interact with distinct regions of the CD4 molecule.
Corbeau P; Haran M; Binz H; Devaux C
Mol Immunol; 1994 Jun; 31(8):569-75. PubMed ID: 8196669
[TBL] [Abstract][Full Text] [Related]
17. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
Fenouillet E; Gluckman JC
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
[TBL] [Abstract][Full Text] [Related]
18. Membrane-interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp120 binding to monoclonal antibody.
Krugner-Higby L; Goff D; Edwards T; Iyer N; Neufeld J; Kute T; Morris-Natschke S; Ishaq K; Piantadosi C; Kucera LS
AIDS Res Hum Retroviruses; 1995 Jun; 11(6):705-12. PubMed ID: 7576930
[TBL] [Abstract][Full Text] [Related]
19. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X; Kinter A; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
[TBL] [Abstract][Full Text] [Related]
20. Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation.
Hillman K; Shapira-Nahor O; Gruber MF; Hooley J; Manischewitz J; Seeman R; Vujcic L; Geyer SJ; Golding H
J Immunol; 1990 Mar; 144(6):2131-9. PubMed ID: 1690235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
